YOUDEN'S TEST FOR CHROMATOGRAPHIC DETERMINATION OF ENALAPRIL IN PHARMACEUTICALS
DOI:
https://doi.org/10.11603/ijmmr.2413-6077.2019.2.10896Keywords:
enalapril, high-performance liquid chromatography, robustness, quantitative analysis, Youden’s testAbstract
Background. Robustness tests were firstly introduced for avoiding problems in interlaboratory studies and identifying the factors potentially responsible. A robustness test performing in late validation procedure involves the possibility that when the method is established not robust, it should be redeveloped and optimized. At this stage much effort has been made and money spent for optimization and validation, and therefore avoiding this would be great.
Objective. The aim of the study was to consider the robustness of HPLC determination of enalapril (in tablets) by the Youden’s test.
Methods. Youden’s test was chosen as an efficient method to assess the robustness among all analytical methods that is by means of an experiment design, which involved seven analytical parameters combined in eight tests. In previous studies, we evaluated the chromatographic method robustness to quantify enalapril (in tablets) by Youden’s test.
Results. According to the Youden’s test criteria, HPLC method proved to be greatly robust regarding the enalapril content in introduction of variation of seven analytic parameters. The lowest variation in enalapril content was 0.91 %, when Grace Platinumр C8 EPS column (4.6 mm i.d. X 250 mm, 5 μm) was used. A holistic approach concerning simultaneous innovations in particle technology and instrument design was endeavored for the first time to meet and tackle the analytical laboratory issues. This was aimed at promoting success of analytical scientists as well as profitability and productiveness of business.
Conclusion. The Youden’s test has been proved to be an efficient and useful tool for evaluation of robustness of enalapril HPLC assay.
References
Faulon JL, Bender A. Handbook of chemoinformatics algorithms. CRC press; 2010 Apr 21:423.
doi: 10.1201/9781420082999 DOI: https://doi.org/10.1201/9781420082999
Youden WJ, Steiner EH. Statistical analysis. Statistical manual of the association of official analytical chemists, Association of Official Analytical Chemists Arlington. 1975:33-83.
César ID, Pianetti GA. Robustness evaluation of the chromatographic method for the quantitation of lumefantrine using Youden's test. Brazilian Journal of Pharmaceutical Sciences. 2009 Jun;45(2):235-40.
doi: 10.1590/S1984-82502009000200007 DOI: https://doi.org/10.1590/S1984-82502009000200007
Karageorgou E, Samanidou V. Youden test application in robustness assays during method validation. Journal of Chromatography A. 2014 Aug 1;1353:131-9.
doi: 10.1016/j.chroma.2014.01.050 DOI: https://doi.org/10.1016/j.chroma.2014.01.050
United States Pharmacopoeia (USP). Medicare Prescription Drug Benefit Model Guidelines Source Information. Available from: http://www.nlm.nih.gov. Accessed 13 Jan 2019.
Logoyda LI, Abdel-Megied AM, Kondratova YU, Trofimenko OL, Korobko D, Dakhym I. Development and validation of HPLC method for the simultaneous determination of enalapril maleate in present of their impurities: Application to tablet analysis. Int J Appl Pharm. 2018;10:98-102.
doi: 10.22159/ijap.2018v10i1.22805 DOI: https://doi.org/10.22159/ijap.2018v10i1.22805
State Pharmacopoeia of Ukraine: in 3 vol. State Enterprise “Ukrainian Scientific Center pharmacopoeia quality medicines”. 2nd ed. Kharkiv: State Enterprise “Ukrainian Scientific Center of Quality pharmacopoeia of medicines”; 2014. p. 724.
State Pharmacopoeia of Ukraine. State Enterprise “Scientific and Expert Centre pharmacopoeia”. 1st ed. Appendix 2. Kharkiv: State Enterprise “Ukrainian Scientific Center of Quality pharmacopoeia of medicines”; 2008. p. 620.
Stanisz B. Evaluation of stability of enalapril maleate in solid phase. Journal of pharmaceutical and biomedical analysis. 2003 Feb 26;31(2):375.
doi: 10.1016/S0731-7085(02)00325-4 DOI: https://doi.org/10.1016/S0731-7085(02)00325-4
Santos EL, de Picoli Souza K, da Silva ED, Batista EC, Martins PJ, D’Almeida V, Pesquero JB. Long term treatment with ACE inhibitor enalapril decreases body weight gain and increases life span in rats. Biochemical pharmacology. 2009 Oct 15;78(8):951-8.
doi: 10.1016/j.bcp.2009.06.018 DOI: https://doi.org/10.1016/j.bcp.2009.06.018
Al-Omari MM, Abdelah MK, Badwan AA, Jaber AM. Effect of the drug-matrix on the stability of enalapril maleate in tablet formulations. Journal of pharmaceutical and biomedical analysis. 2001 Jul 1;25(5-6):893-902.
doi: 10.1016/S0731-7085(01)00399-5 DOI: https://doi.org/10.1016/S0731-7085(01)00399-5
Gu L, Strickley RG. A profound solvent effect on the diketopiperazine formation of the new dipeptide angiotensin-converting enzyme inhibitor, moexipril. International Journal of Pharmaceutics. 1990 Apr 30;60(2):99-107.
doi: 10.1016/0378-5173(90)90295-F DOI: https://doi.org/10.1016/0378-5173(90)90295-F
Stanisz BE. Kinetics of degradation of enalapril maleate in dosage forms. Acta Pol. Pharm. 2004;61:415-8.
Lima DM, dos Santos LD, Lima EM. Stability and in vitro release profile of enalapril maleate from different commercially available tablets: possible therapeutic implications. Journal of pharmaceutical and biomedical analysis. 2008 Aug 5;47(4-5):934.
doi: 10.1016/j.jpba.2008.02.030 DOI: https://doi.org/10.1016/j.jpba.2008.02.030
Roškar R, Simončič Z, Gartner A, Kmetec V. Stability of new potential ACE inhibitor in the aqueous solutions of different pH. Journal of pharmaceutical and biomedical analysis. 2009 Feb 20;49(2):295.
doi: 10.1016/j.jpba.2008.11.029 DOI: https://doi.org/10.1016/j.jpba.2008.11.029
Melander WR, Jacobson J, Horváth C. Effect of molecular structure and conformational change of proline-containing dipeptides in reversed-phase chromatography. Journal of Chromatography A. 1982 Jan 15;234(2):269-76.
doi: 10.1016/S0021-9673(00)81865-8 DOI: https://doi.org/10.1016/S0021-9673(00)81865-8
Mohan MA, Haider SZ, Anand AK, Srivastva AK. Validation of stability indicating HPLC method for the determination of enalapril maleate in tablet formulations. International Journal of Pharmacy and Pharmaceutical Sciences. 2011;3:180-3.
ICH Q2 (R1), Validation of analytical procedures, Text and methodology. International Conference on Harmonization, Geneva; 2005. p. 1-17. Available from: http://www.gmp-compliance.org/guidemgr/files/Q2(R1).PDF Accessed 18 Jul 2019.
